HELC_ASPFU
ID HELC_ASPFU Reviewed; 257 AA.
AC Q4WR19;
DT 25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2005, sequence version 1.
DT 03-AUG-2022, entry version 92.
DE RecName: Full=Short chain dehydrogenase helC {ECO:0000303|PubMed:29158519};
DE EC=1.1.1.- {ECO:0000269|PubMed:19415934, ECO:0000269|PubMed:29158519};
DE AltName: Full=Helvolic acid biosynthesis cluster protein helC {ECO:0000303|PubMed:29158519};
DE Flags: Precursor;
GN Name=helC {ECO:0000303|PubMed:29158519};
GN Synonyms=sdr1 {ECO:0000303|PubMed:19415934}; ORFNames=AFUA_4G14800;
OS Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC
OS A1100) (Aspergillus fumigatus).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Fumigati.
OX NCBI_TaxID=330879;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100;
RX PubMed=16372009; DOI=10.1038/nature04332;
RA Nierman W.C., Pain A., Anderson M.J., Wortman J.R., Kim H.S., Arroyo J.,
RA Berriman M., Abe K., Archer D.B., Bermejo C., Bennett J.W., Bowyer P.,
RA Chen D., Collins M., Coulsen R., Davies R., Dyer P.S., Farman M.L.,
RA Fedorova N., Fedorova N.D., Feldblyum T.V., Fischer R., Fosker N.,
RA Fraser A., Garcia J.L., Garcia M.J., Goble A., Goldman G.H., Gomi K.,
RA Griffith-Jones S., Gwilliam R., Haas B.J., Haas H., Harris D.E.,
RA Horiuchi H., Huang J., Humphray S., Jimenez J., Keller N., Khouri H.,
RA Kitamoto K., Kobayashi T., Konzack S., Kulkarni R., Kumagai T., Lafton A.,
RA Latge J.-P., Li W., Lord A., Lu C., Majoros W.H., May G.S., Miller B.L.,
RA Mohamoud Y., Molina M., Monod M., Mouyna I., Mulligan S., Murphy L.D.,
RA O'Neil S., Paulsen I., Penalva M.A., Pertea M., Price C., Pritchard B.L.,
RA Quail M.A., Rabbinowitsch E., Rawlins N., Rajandream M.A., Reichard U.,
RA Renauld H., Robson G.D., Rodriguez de Cordoba S., Rodriguez-Pena J.M.,
RA Ronning C.M., Rutter S., Salzberg S.L., Sanchez M., Sanchez-Ferrero J.C.,
RA Saunders D., Seeger K., Squares R., Squares S., Takeuchi M., Tekaia F.,
RA Turner G., Vazquez de Aldana C.R., Weidman J., White O., Woodward J.R.,
RA Yu J.-H., Fraser C.M., Galagan J.E., Asai K., Machida M., Hall N.,
RA Barrell B.G., Denning D.W.;
RT "Genomic sequence of the pathogenic and allergenic filamentous fungus
RT Aspergillus fumigatus.";
RL Nature 438:1151-1156(2005).
RN [2]
RP INDUCTION.
RX PubMed=17432932; DOI=10.1371/journal.ppat.0030050;
RA Perrin R.M., Fedorova N.D., Bok J.W., Cramer R.A., Wortman J.R., Kim H.S.,
RA Nierman W.C., Keller N.P.;
RT "Transcriptional regulation of chemical diversity in Aspergillus fumigatus
RT by LaeA.";
RL PLoS Pathog. 3:E50-E50(2007).
RN [3]
RP FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX PubMed=19415934; DOI=10.1021/ja8095976;
RA Mitsuguchi H., Seshime Y., Fujii I., Shibuya M., Ebizuka Y., Kushiro T.;
RT "Biosynthesis of steroidal antibiotic fusidanes: functional analysis of
RT oxidosqualene cyclase and subsequent tailoring enzymes from Aspergillus
RT fumigatus.";
RL J. Am. Chem. Soc. 131:6402-6411(2009).
RN [4]
RP FUNCTION.
RX PubMed=19216560; DOI=10.1021/ol802696a;
RA Lodeiro S., Xiong Q., Wilson W.K., Ivanova Y., Smith M.L., May G.S.,
RA Matsuda S.P.;
RT "Protostadienol biosynthesis and metabolism in the pathogenic fungus
RT Aspergillus fumigatus.";
RL Org. Lett. 11:1241-1244(2009).
RN [5]
RP INDUCTION.
RX PubMed=25311525; DOI=10.1186/1471-2164-15-894;
RA O'Keeffe G., Hammel S., Owens R.A., Keane T.M., Fitzpatrick D.A.,
RA Jones G.W., Doyle S.;
RT "RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin
RT self-protection mechanism in Aspergillus fumigatus.";
RL BMC Genomics 15:894-894(2014).
RN [6]
RP FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX PubMed=29158519; DOI=10.1038/s41467-017-01813-9;
RA Lv J.M., Hu D., Gao H., Kushiro T., Awakawa T., Chen G.D., Wang C.X.,
RA Abe I., Yao X.S.;
RT "Biosynthesis of helvolic acid and identification of an unusual C-4-
RT demethylation process distinct from sterol biosynthesis.";
RL Nat. Commun. 8:1644-1644(2017).
CC -!- FUNCTION: Short chain dehydrogenase; part of the gene cluster that
CC mediates the biosynthesis of helvolic acid, an antibacterial
CC nortriterpenoid (PubMed:19415934, PubMed:19216560, PubMed:29158519).
CC Protostadienol synthase helA cyclizes (3S)-oxidosqualene to (17Z)-
CC protosta-17(20),24-dien-3-beta-ol (protostadienol)(PubMed:19415934,
CC PubMed:19216560, PubMed:29158519). The synthesis of protostadienol is
CC followed by several steps of monooxygenation, dehydrogenation, and acyl
CC transfer to yield the final helvolic acid (PubMed:19216560). Following
CC the cyclization to the tetracyclic protostadienol by helA, cytochrome
CC P450 monooxygenases helB1-mediated and helB2-mediated oxidation at C-4
CC and C-16, acyltransferase helD2-dependent acetylation of 16-OH,
CC oxidation of C-21 by cytochrome P450 monooxygenase helB4, and short
CC chain dehydrogenase helC-dependent oxidative decarboxylation yield the
CC fusidane skeleton (PubMed:29158519). This intermediate is further
CC modified in three additional steps mediated by the cytochrome P450
CC monooxygenase helB3, the acyltransferase helD1, and the 3-ketosteroid
CC 1-dehydrogenase helE to give helvolic acid (PubMed:19415934,
CC PubMed:19216560, PubMed:29158519). Compared with the late stages in the
CC biosynthesis of helvolic acid, enzymes involved in the early stage
CC modifications act in a relatively strict order (PubMed:29158519). The
CC hydroxylation of C-16 by helB1 and subsequent acetylation by helD2
CC should occur before the helB3-mediated oxidation of C-21
CC (PubMed:29158519). C-4 demethylation in fusidane-type antibiotics
CC proceeds in an unusual manner though it is also achieved by oxidative
CC decarboxylation (PubMed:19415934, PubMed:29158519). The methyl group at
CC C-4 beta position is oxidized by helB1 and subsequently removed by the
CC short chain dehydrogenase helC (PubMed:19415934, PubMed:29158519).
CC {ECO:0000269|PubMed:19216560, ECO:0000269|PubMed:19415934,
CC ECO:0000269|PubMed:29158519}.
CC -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:19415934,
CC ECO:0000269|PubMed:29158519}.
CC -!- INDUCTION: Expression is under the control of the secondary metabolism
CC regulator laeA (PubMed:17432932). Expression up-regulated upon exposure
CC to exogenous gliotoxin (PubMed:25311525). {ECO:0000269|PubMed:17432932,
CC ECO:0000269|PubMed:25311525}.
CC -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AAHF01000005; EAL89315.1; -; Genomic_DNA.
DR RefSeq; XP_751353.1; XM_746260.1.
DR AlphaFoldDB; Q4WR19; -.
DR SMR; Q4WR19; -.
DR STRING; 746128.CADAFUBP00007023; -.
DR EnsemblFungi; EAL89315; EAL89315; AFUA_4G14800.
DR GeneID; 3508871; -.
DR KEGG; afm:AFUA_4G14800; -.
DR VEuPathDB; FungiDB:Afu4g14800; -.
DR eggNOG; KOG4169; Eukaryota.
DR HOGENOM; CLU_010194_2_10_1; -.
DR InParanoid; Q4WR19; -.
DR OMA; IYATQQA; -.
DR OrthoDB; 1053465at2759; -.
DR Proteomes; UP000002530; Chromosome 4.
DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IBA:GO_Central.
DR GO; GO:1900812; P:helvolic acid biosynthetic process; IDA:GO_Central.
DR GO; GO:0019748; P:secondary metabolic process; IGC:AspGD.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR InterPro; IPR002347; SDR_fam.
DR Pfam; PF00106; adh_short; 1.
DR PRINTS; PR00081; GDHRDH.
DR PRINTS; PR00080; SDRFAMILY.
DR SUPFAM; SSF51735; SSF51735; 1.
DR PROSITE; PS00061; ADH_SHORT; 1.
PE 1: Evidence at protein level;
KW Glycoprotein; NAD; Oxidoreductase; Reference proteome; Signal.
FT SIGNAL 1..22
FT /evidence="ECO:0000255"
FT CHAIN 23..257
FT /note="Short chain dehydrogenase helC"
FT /id="PRO_0000441953"
FT ACT_SITE 154
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT BINDING 11..34
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250|UniProtKB:Q12634"
FT CARBOHYD 46
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT CARBOHYD 110
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ SEQUENCE 257 AA; 27460 MW; F39D2928B994A82C CRC64;
MNTAIITGAA QGVGLCIAEA LAQRNYRIVL SDIDTEKGPA AASKLNLTHG EGTAAFFHCD
LSNLREIDAL LSFTIETMGG FSVLINNAGY LRAPFLALSA QDIQDMITVN LTAPIYATQQ
AIKYWDGLHQ GQAGCVVSVT SSSSFKTYAS IAPYGAAKAG AAMFTFAAGA FHPRVRVNAV
APTAIATGFD KNRMRVETDR TGPGYTPEEE MRAMGLKRLQ PQEVAEAVVR CVEDKGLYGK
VLYLDAVEGI KIHDGYT